tiprankstipranks
Trinity Biotech Plc (TRIB)
NASDAQ:TRIB
US Market

Trinity Biotech (TRIB) Income Statement

Compare
315 Followers

Trinity Biotech Income Statement

Last quarter (Q3 2024), Trinity Biotech's total revenue was $15.15M, an increase of 3.24% from the same quarter last year. In Q3, Trinity Biotech's net income was $-4.76M. See Trinity Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 56.83M$ 74.78M$ 92.97M$ 101.98M$ 90.44M
Gross Profit
$ 19.45M$ 22.05M$ 38.08M$ 48.58M$ 38.12M
Operating Expenses
$ 46.49M$ 32.96M$ 24.51M$ 28.30M$ 32.82M
Depreciation and Amortization
$ 1.78M$ 2.33M$ 2.74M$ 3.08M$ 4.89M
EBITDA
$ -24.10M$ -16.71M$ 10.59M$ 21.52M$ -19.52M
Operating Income
$ -27.05M$ -10.91M$ 13.15M$ 19.11M$ 872.00K
Other Income/Expenses
$ -9.88M$ -24.43M$ -5.86M$ -6.71M$ -5.88M
Pretax Income
$ -36.93M$ -41.19M$ 751.00K$ -6.63M$ 821.00K
Net Income
$ -24.02M$ -41.00M$ 875.00K$ -6.01M$ -4.07M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.16$ -6.08$ 0.20$ -1.44$ -0.97
Diluted EPS
$ -0.16$ -5.27$ 0.20$ -1.44$ -0.80
Weighted Average Shares Outstanding
153.10M 6.75M 4.18M 4.18M 4.18M
Weighted Average Shares Outstanding (Diluted)
153.10M 7.77M 5.33M 4.18M 5.09M
Currency in USD

Trinity Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis